Sei Investments Co. Buys 7,137 Shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA)

Sei Investments Co. increased its stake in shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRAFree Report) by 6.5% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 116,695 shares of the real estate investment trust’s stock after buying an additional 7,137 shares during the quarter. Sei Investments Co.’s holdings in Sabra Health Care REIT were worth $1,797,000 at the end of the most recent quarter.

Other institutional investors have also bought and sold shares of the company. Natixis purchased a new position in Sabra Health Care REIT in the first quarter worth $633,000. BNP PARIBAS ASSET MANAGEMENT Holding S.A. boosted its position in Sabra Health Care REIT by 63.6% in the first quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 318,808 shares of the real estate investment trust’s stock worth $4,709,000 after purchasing an additional 123,966 shares during the last quarter. Cetera Advisors LLC boosted its position in Sabra Health Care REIT by 996.2% in the first quarter. Cetera Advisors LLC now owns 149,574 shares of the real estate investment trust’s stock worth $2,209,000 after purchasing an additional 135,929 shares during the last quarter. Cetera Investment Advisers boosted its position in Sabra Health Care REIT by 34.1% in the first quarter. Cetera Investment Advisers now owns 406,675 shares of the real estate investment trust’s stock worth $6,007,000 after purchasing an additional 103,413 shares during the last quarter. Finally, Envestnet Asset Management Inc. boosted its position in Sabra Health Care REIT by 7.1% in the second quarter. Envestnet Asset Management Inc. now owns 579,110 shares of the real estate investment trust’s stock worth $8,918,000 after purchasing an additional 38,144 shares during the last quarter. Institutional investors own 99.40% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have weighed in on SBRA. Citigroup raised Sabra Health Care REIT from a “neutral” rating to a “buy” rating and boosted their price objective for the stock from $17.00 to $20.00 in a research report on Friday, September 13th. Wells Fargo & Company raised Sabra Health Care REIT from an “equal weight” rating to an “overweight” rating and boosted their price objective for the stock from $16.00 to $20.00 in a research report on Tuesday, October 1st. Truist Financial upped their price target on Sabra Health Care REIT from $16.00 to $18.00 and gave the company a “buy” rating in a research report on Wednesday, September 4th. Finally, Scotiabank upped their price target on Sabra Health Care REIT from $15.00 to $17.00 and gave the company a “sector perform” rating in a research report on Monday, August 26th. Two analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $17.80.

Read Our Latest Stock Report on Sabra Health Care REIT

Sabra Health Care REIT Stock Performance

Shares of SBRA opened at $17.97 on Friday. The stock’s 50-day simple moving average is $17.32 and its 200 day simple moving average is $15.59. The stock has a market capitalization of $4.16 billion, a price-to-earnings ratio of 89.85, a price-to-earnings-growth ratio of 2.64 and a beta of 1.26. The company has a debt-to-equity ratio of 0.89, a quick ratio of 4.27 and a current ratio of 4.27. Sabra Health Care REIT, Inc. has a 52-week low of $12.83 and a 52-week high of $19.32.

Sabra Health Care REIT (NASDAQ:SBRAGet Free Report) last issued its quarterly earnings data on Wednesday, August 7th. The real estate investment trust reported $0.10 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.34 by ($0.24). The company had revenue of $176.14 million for the quarter, compared to analysts’ expectations of $166.54 million. Sabra Health Care REIT had a return on equity of 1.87% and a net margin of 7.83%. The business’s revenue for the quarter was up 9.3% on a year-over-year basis. During the same period last year, the company posted $0.34 EPS. Research analysts forecast that Sabra Health Care REIT, Inc. will post 1.38 EPS for the current fiscal year.

Sabra Health Care REIT Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, August 30th. Investors of record on Monday, August 19th were issued a dividend of $0.30 per share. The ex-dividend date was Monday, August 19th. This represents a $1.20 dividend on an annualized basis and a yield of 6.68%. Sabra Health Care REIT’s dividend payout ratio (DPR) is 600.00%.

Sabra Health Care REIT Company Profile

(Free Report)

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing – Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing – Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.

Further Reading

Want to see what other hedge funds are holding SBRA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sabra Health Care REIT, Inc. (NASDAQ:SBRAFree Report).

Institutional Ownership by Quarter for Sabra Health Care REIT (NASDAQ:SBRA)

Receive News & Ratings for Sabra Health Care REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Health Care REIT and related companies with MarketBeat.com's FREE daily email newsletter.